v3.25.4

Segment information (Tables)

9 Months Ended

Dec. 31, 2025

Segment Reporting [Abstract]

Schedule of Financial Information Including Significant Segment Expenses by Program

The following table presents selected financial information with respect to the Company's single operating segment, including significant segment expenses by program, for the three and nine months ended December 31, 2025 and 2024:

			Three Months Ended December 31,												Nine Months Ended December 31,
			2025						2024						2025						2024
Operating expenses:			(Amounts in thousands)
Direct research and development expenses by program:
RP1 program costs by study:
IGNYTE			2,059						3,226						8,073						10,831
ARTACUS			1,663						1,787						4,898						5,211
CERPASS			1,012						1,611						3,653						5,573
IGNYTE-3			4,219						2,375						15,554						4,909
Other RP1 study costs			5,200						1,590						15,162						7,075
RP2			7,729						4,409						16,857						8,322
RP3			826						1,434						2,262						3,856
Unallocated research and development expenses¹:			30,432						31,572						102,401						89,695
Selling, general and administrative			18,728						18,015						77,721						46,827
Total operating expenses			71,868						66,019						246,581						182,299
Loss from operations			(71,868)						(66,019)						(246,581)						(182,299)
Other income (expense), net			627						$	254					$	5,547					$	9,707
Loss before income taxes			$	(71,241)					$	(65,765)					$	(241,034)					$	(172,592)
Income tax (benefit) provision			(311)						575						(311)						575
Net loss			(70,930)						(66,340)						(240,723)						(173,167)

1Includes personnel-related costs and other costs

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration